|
An analysis of the short- and long-term cost-effectiveness of starting biphasic insulin aspart 30 in insulin-naive people with poorly controlled type 2 diabetes |
Shafie AA, Gupta V, Baabbad R, Hammerby E, Home P |
|
|
Record Status This is an economic evaluation that meets the criteria for inclusion on NHS EED. Bibliographic details Shafie AA, Gupta V, Baabbad R, Hammerby E, Home P. An analysis of the short- and long-term cost-effectiveness of starting biphasic insulin aspart 30 in insulin-naive people with poorly controlled type 2 diabetes. Diabetes Research and Clinical Practice 2014: epub Indexing Status Subject indexing assigned by NLM MeSH Adult; Aged; Algeria; Autoimmune Diseases; Biphasic Insulins /economics /therapeutic use; Cost-Benefit Analysis; Diabetes Mellitus, Type 2 /blood /drug therapy /economics; Female; Health Care Costs; Hemoglobin A, Glycosylated /metabolism; Humans; Hypoglycemic Agents /economics /therapeutic use; India; Indonesia; Insulin Aspart /economics /therapeutic use; Insulin, Isophane /economics /therapeutic use; Life Expectancy; Male; Middle Aged; Quality-Adjusted Life Years; Saudi Arabia; Time Factors; Treatment Outcome AccessionNumber 22014038543 Date bibliographic record published 08/12/2014 |
|
|
|